Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis
{{output}}
Background and aims: Currently, there is no pharmacotherapy for non-alcoholic steatohepatitis (NASH), a common liver disorder. In contrast, primary biliary cholangitis (PBC) is a chronic cholestatic liver disease for which ursode... ...
